Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug4049 | Traditional Proning Arm Wiki | 1.00 |
| drug2729 | Oseltamivir Wiki | 0.38 |
| drug421 | Azithromycin Wiki | 0.16 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| D012127 | Respiratory Distress Syndrome, Newborn NIH | 0.08 |
| D055371 | Acute Lung Injury NIH | 0.08 |
| D012128 | Respiratory Distress Syndrome, Adult NIH | 0.07 |
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
Prone positioning is one of the few therapies known to improve mortality in ARDS. Traditionally, patients are proned for 16 hours per 24 hour period. Some retrospective data suggests improvement may persist beyond 16 hours. We aim to perform a pilot study comparing traditional prone positioning to prolonged prone positioning in patients with COVID-induced ARDS.
Description: Time spent in the prone position
Measure: Duration in prone position Time: 96 hoursDescription: Change in P:F ratio from immediately prior to initiation of prone positioning to end of study period
Measure: Change in P:F ratio Time: 96 hoursDescription: Change in drive pressure from immediately prior to initiation of prone positioning to end of the study period
Measure: Drive Pressure Time: 96 hoursDescription: Unplanned extubations
Measure: Unplanned extubations Time: 96 hoursDescription: Pressure ulcers
Measure: Pressure ulcers Time: 96 hoursDescription: Displacement of central venous line or arterial line
Measure: Line displacement Time: 96 hoursDescription: Duration of mechanical ventilation
Measure: Duration of mechanical ventilation Time: 30 daysDescription: Mortality
Measure: Mortality Time: 30 daysDescription: New initiation of inhaled pulmonary vasodilators, ECMO
Measure: Rescue Interventions Time: 96 hoursAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports